LIFECARE ASA (LIFE.OL) Stock Price, Forecast & Analysis
Europe - Euronext Oslo - OSL:LIFE - NO0013355859 - Common Stock
LIFE.OL Key Statistics, Chart & Performance
The current stock price of LIFE.OL is 4.75 NOK. In the past month the price decreased by -11.05%. In the past year, price decreased by -64.68%.
LIFE.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.28 | 112.53B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 18.38 | 49.34B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 21.98 | 47.12B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.31 | 22.62B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.28 | 22.57B | ||
| BIM.PA | BIOMERIEUX | 27.9 | 12.75B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.36 | 3.88B | ||
| DIA.MI | DIASORIN SPA | 17.16 | 3.33B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.57 | 1.28B | ||
| DRW8.DE | DRAEGERWERK AG | 9.4 | 1.14B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.22 | 982.65M | ||
| ELN.MI | EL.EN. SPA | 18.39 | 944.31M |
Related stock screener links
About LIFE.OL
Company Profile
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 30 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Company Info
LIFECARE ASA
Ytrebygdsvegen 215
Bergen HORDALAND NO
Employees: 32
Phone: 4740059040
LIFECARE ASA / LIFE.OL FAQ
What does LIFECARE ASA do?
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 30 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
What is the current price of LIFE stock?
The current stock price of LIFE.OL is 4.75 NOK. The price increased by 3.26% in the last trading session.
Does LIFECARE ASA pay dividends?
LIFE.OL does not pay a dividend.
What is the ChartMill technical and fundamental rating of LIFE stock?
LIFE.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is LIFE.OL stock listed?
LIFE.OL stock is listed on the Euronext Oslo exchange.
What is the analyst forecast for LIFE.OL stock?
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 673.05% is expected in the next year compared to the current price of 4.75.
Can you provide the market cap for LIFECARE ASA?
LIFECARE ASA (LIFE.OL) has a market capitalization of 90.53M NOK. This makes LIFE.OL a Micro Cap stock.
LIFE.OL Technical Analysis
LIFE.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LIFE.OL. LIFE.OL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
LIFE.OL Financial Highlights
Over the last trailing twelve months LIFE.OL reported a non-GAAP Earnings per Share(EPS) of -16.64. The EPS decreased by -40.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -93.35% | ||
| ROE | -124.42% | ||
| Debt/Equity | 0.12 |
LIFE.OL Forecast & Estimates
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 673.05% is expected in the next year compared to the current price of 4.75.
For the next year, analysts expect an EPS growth of 4.06% and a revenue growth -50% for LIFE.OL